British Research Panel

  • Home
  • British Research Panel
Directions Website

British Research Panel As a member of The British Research Panel you become part of an effort to advance research. Please note. Many of the comments include health-related advice.

Community Rules:

Welcome to the British Research Panel’s community! We engage patients in clinical trials and offer this group as a safe space to discuss everything related to clinical research, health, and the needs of patients in our patient community. We encourage your feedback and aim to respond to your comments in a timely, informative and friendly manner. While we do moderate this community including the comments on our ads, we welcome an open discussion. Please always consult your doctor before incorporating any changes to your treatment plan or including additional medication to your current therapy. This also includes alternative medicine. To help everyone enjoy our community, we ask that when you post or react to other comments, you keep in mind the following:

Be kind. Insulting, name-calling or bullying others will result in your comment being deleted, and you risk being banned from the group or comment section without warning. Be civil. We don’t accept defamatory, indecent, offensive, discriminatory, misleading, misinformation or threatening comments. Breaking this rule once will lead to the deletion of your comment and a warning. Doing it repeatedly will result in you being banned from our Facebook community. Be open-minded. Other people in the community will have had different life experiences and may have a different perspective to yours. We welcome different viewpoints. No advertising. Don’t use the group to advertise yours or someone else’s business, page, or website. While we do encourage an open discussion on treatment options, we do not accept any kind of affiliated links to medication. These posts will be immediately removed, and you will risk being banned from our Facebook community. Use English only. To make sure all members of the group understand you, please only use the English language. Stick to the topic. We only allow posts and comments related to clinical trials and health-related issues. Off-topic content and comments will risk being removed. No spamming. Asking the same question or posting the same comment repeatedly after it has been resolved or removed by the British Research Panel due to rule violation will result in a ban. Report rule breaking. If you see a post/comment that violates our rules or Facebooks community standards, please report it. Don’t report posts or comments that aren’t breaking any rules just because you don’t like or agree with their content. Be cautious. This is a public place. We recommend that you don’t post any information that may identify you or anyone else, such as your address, email address or phone number. If you want or need to share any of that information with us as, please send an email to [email protected]

Talk to the British Research Panel. If you have any questions or concerns, or are experiencing issues in the group, please tag British Research Panel or send an e-mail to [email protected]

AI model may predict pancreatic cancer risk up to 5 years before diagnosis💻Researchers have developed an artificial inte...
09/11/2026

AI model may predict pancreatic cancer risk up to 5 years before diagnosis💻

Researchers have developed an artificial intelligence (AI) model that could help identify people at increased risk of pancreatic cancer up to five years before diagnosis, potentially creating new opportunities for earlier detection.

The model was developed using electronic health records and routine blood test results from almost 40,000 people. By analysing patterns in patients’ medical histories over time, the AI identified signals associated with a higher risk of developing pancreatic cancer.

Read more👇
https://britishresearchpanel.co.uk/2026/10/15/ai-model-may-predict-pancreatic-cancer-risk-up-to-5-years-before-diagnosis/

After the discovery of a lump in his neck, Solomon was diagnosed with Multiple Myeloma in 2018. Whilst undergoing many d...
06/11/2026

After the discovery of a lump in his neck, Solomon was diagnosed with Multiple Myeloma in 2018. Whilst undergoing many different treatments, he began to study his health and results to better understand his condition. This led him to question how his experience could help shape research and the importance of the patient’s voice.

Determined to contribute, Solomon joined patient advisory groups, reviewed clinical trial protocols and worked alongside researchers, clinicians and patient organisations. He also created the Through MYeloma Eyes podcast, not just as an outlet and reflection for himself, but also to be a safe space for others going through a similar experience to realise that they are not alone.

Read his story: https://britishresearchpanel.co.uk/2026/08/26/from-patient-to-voice-my-myeloma-story/

Who is behind a clinical trial? Meet the people who make clinical research possible. 👩‍⚕️🏥When you take part in a clinic...
02/11/2026

Who is behind a clinical trial? Meet the people who make clinical research possible. 👩‍⚕️🏥

When you take part in a clinical trial, you may mainly interact with a doctor, research nurse or study coordinator. But behind every appointment, test, study medication and piece of information collected is a much larger team. Clinical research brings together healthcare professionals, scientists, coordinators, data specialists and independent organisations, each with a different responsibility.

In this article, we take a closer look at some of the main people involved in a clinical trial, including those you may meet during the study and many others working behind the scenes.👇

https://britishresearchpanel.co.uk/2026/10/01/who-is-behind-a-clinical-trial-meet-the-people-who-make-clinical-research-possible/

New hope for breast cancer patients as life-extending drug now on NHS in England 🎀💗A life-extending breast cancer drug i...
30/10/2026

New hope for breast cancer patients as life-extending drug now on NHS in England 🎀💗

A life-extending breast cancer drug is now available on the NHS in England for people with a specific type of incurable breast cancer, following years of campaigning by patients and charities.

Enhertu (trastuzumab deruxtecan) is a targeted treatment for people with HER2-low metastatic breast cancer. Clinical evidence has shown that the drug can extend survival and delay the progression of the disease compared with chemotherapy. NICE previously decided in 2024 that Enhertu was not a cost-effective use of NHS resources.

Read more👇
https://britishresearchpanel.co.uk/2026/09/22/new-hope-for-breast-cancer-patients-as-life-extending-drug-now-on-nhs-in-england/

🔵 October 25th-31st is Respiratory Care WeekEvery breath counts. This week, we celebrate the respiratory care profession...
26/10/2026

🔵 October 25th-31st is Respiratory Care Week

Every breath counts.

This week, we celebrate the respiratory care professionals who help people breathe easier every day, and shine light on lung conditions like COPD.

COPD (chronic obstructive pulmonary disease) is a long-term lung condition that makes it harder to breathe. It often develops slowly, and many people put early symptoms down to getting older or being less fit.

There are practical steps you can take to look after your lungs:
✅ If you smoke, ask for support to quit. It's the most important step for your lung health.
✅ Ask your doctor which vaccinations are recommended for you, such as the flu vaccine.
✅ Stay as active as you can, and ask whether pulmonary rehabilitation could help you.
✅ If you use an inhaler, check with your care team that you're using it correctly.

If you notice persistent breathlessness, a long-lasting cough, or frequent chest infections, speak to your healthcare provider.

With the right care and support, many people with COPD can stay active and enjoy a good quality of life. 💙

📚💙 National Health Education Week | 19th –23rd OctoberUnderstanding your health can help you feel more informed, confide...
24/10/2026

📚💙 National Health Education Week | 19th –23rd October

Understanding your health can help you feel more informed, confident and involved in decisions about your care.

At the British Research Panel, we believe that health education and access to clear information about medical research matter. As an online patient community, we share research news, patient stories and opportunities to learn more about clinical studies.

🔬 Want to stay informed? Follow us and join our community to keep up with the latest research, health topics, and opportunities to get involved.

It's important to take care of your health.

Join our community👇
https://answer.britishresearchpanel.co.uk/survey/selfserve/481b/241000?list=0&norestore=1&utm_source=web #?

Personalised Cancer Vaccine Shows Promise in Preventing Melanoma Returning 💉A personalised cancer vaccine has shown prom...
23/10/2026

Personalised Cancer Vaccine Shows Promise in Preventing Melanoma Returning 💉

A personalised cancer vaccine has shown promising results in a Phase 3 clinical trial, helping to prevent melanoma from returning in patients at high risk of their cancer coming back.

Experts have described the findings as an important step forward for personalised cancer treatment, although the full Phase 3 results are yet to be released and independently reviewed.

Read more👇
https://britishresearchpanel.co.uk/2026/08/26/personalised-cancer-vaccine-shows-promise-in-preventing-melanoma-returning/

Why Might You Not Be Eligible for a Clinical Trial🔬👩‍🔬When you find a clinical study concerning your condition, it may s...
16/10/2026

Why Might You Not Be Eligible for a Clinical Trial🔬👩‍🔬

When you find a clinical study concerning your condition, it may seem natural to assume that you will be able to participate. However, every clinical study has specific requirements for who can take part. You may therefore be told that the study is not suitable for you, even if you have the condition being investigated.

This can feel disappointing, but it is important to understand that being ineligible is not a judgement of you as a person. It does not necessarily mean that you are too ill or not ill enough. It usually means only that you do not meet every requirement for that particular study.

Read about what factors may affect eligibility, how eligibility is assessed and it's importance.👇
https://britishresearchpanel.co.uk/2026/08/01/why-might-you-not-be-eligible-for-a-clinical-trial/

More Women in their 20s are Getting Type 2 Diabetes 🍭A new analysis of NHS data has found a worrying increase in type 2 ...
12/10/2026

More Women in their 20s are Getting Type 2 Diabetes 🍭

A new analysis of NHS data has found a worrying increase in type 2 diabetes among young adults in England, particularly women in their 20s.

Researchers at Imperial College London analysed data from the English National Diabetes Audit between 2011 and 2024 and found that, while diagnoses have fallen slightly among older adults, rates have risen rapidly in people under 40.

Around 12,000 people under the age of 30 are now living with type 2 diabetes, with women accounting for a growing proportion of these younger cases.

Read morehttps://britishresearchpanel.co.uk/2026/07/15/more-women-in-their-20s-are-getting-type-2-diabetes/

Address


Alerts

Be the first to know and let us send you an email when British Research Panel posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your business to be the top-listed health & beauty business?

Share